Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
atopic dermatitis
Biotech
Enveda envisions clinical wins with $130M series C raise
The Boulder-based biotech sent its lead candidate ENV-294 into a phase 1 trial for atopic dermatitis at the end of October.
Darren Incorvaia
Nov 21, 2024 10:55am
Rapt's share price sinks after shelving AD drug under FDA hold
Nov 11, 2024 9:44am
Amgen reports first phase 3 win for $400M eczema drug
Sep 25, 2024 5:50am
Connect reduces China workforce, mulls strategy for asthma drug
Sep 6, 2024 4:37am
Aslan’s dream of challenging Dupixent dies as biotech winds down
Jul 17, 2024 8:36am
J&J scoops up another atopic dermatitis drug for $1.25B
May 28, 2024 8:30am
